Skip to main content

  • Register Today

    Learn more about meeting registration.

    Club Jules Gonin

      ASRS Logo

     

      

    		 Macula Society Logo

    In conjunction with the American Society of Retina Specialists, the Macula Society, the Retina Society and Club Jules Gonin

    Looking to the Future

    Engage with the latest research while learning about new vitreoretinal imaging, surgical instruments and techniques.

    Friday, Nov. 3 and Saturday, Nov. 4
    Moscone Center, San Francisco, CA

    Program Directors

    Timothy G. Murray, MD, MBA and Barbara Ann Blodi MD

    Program Planning Group

    Sophie J Bakri MD , Barbara Ann Blodi MD, Diana V Do MD, and Timothy G Murray MD MBA

    Late Breaking Developments

    The online abstract submitter is now closed. Notifications will go out the week of Sept. 4.

    Program

    Day 1

    • Section I: Neovascular AMD (RET 02)

    • Section II: Public Health, Education and the Business of Retina (RET 03)

    • The Charles L Schepens MD Lecture (RET 04)

    • Section III: My Best Medical Retina Case (RET 05)

    • Section IV: Medical Retina and Chorioretinal Vascular Disease (RET 06)

    • Section V: Vitreoretinal Surgery, Part I (RET 07)

    • Section VI: Oncology (RET 08)

    • Section VII: The 2023 Debates (RET 09)

    • Section VIII: Late Breaking Developments, Part I (RET 10)

    • Section IX: First-time Results of Clinical Trials (RET 11)

    Day 2

    • Section X: Imaging (RET 13)

    • Section XI: Late Breaking Developments, Part II (RET 14)

    • Section XII: Non-exudative AMD (RET 15)

    • Section XIII: Uveitis (RET 16)

    • Section XIV: Diabetic Retinopathy (RET 17)

    • Section XV: Pediatric Retina (RET 18)

    • Section XVI: Gene and Cell-Based and Neuro-protection Therapies (RET 19)

    • Section XVII: Artificial Intelligence (RET 20)

    • Section XVIII: Vitreoretinal Surgery, Part II (RET 21)

    • Section XIX: Surgical Videos—Cool Cases and Complications (RET 22)

    View the full schedule in the Mobile Meeting Guide. Click the Program button on the homepage, then select Program Search. Choose among the Subspecialty Day meeting options under the "Filter by Meeting" drop-down menu. You can select multiple filters/meetings.

    Mission Statement

    The 2023 Retina Subspecialty Day aims to provide a comprehensive and focused medical and surgical retina update for the retina specialist, interested ophthalmologist, and ophthalmologist-in-training. The meeting focuses on up-to-date, clinically, and scientifically relevant retina topics presented by an international group of respected, expert retina specialists. The major educational goal is to highlight new medical and surgical clinical advances and research outcomes and present them in ways that are useful for patient care. The meeting achieves this objective by engaging meeting participants in didactic presentations, case presentations, videos, debates, exhibits, panel discussions, and audience response polling.

    Target Audience

    The intended target audience for this program is retinal specialists, members in training, and general ophthalmologists who are engaged in the diagnosis and treatment of vitreoretinal diseases.

    Education Level

    Intermediate, Advanced

    Goals

    The goals of this program are to:

    • Provide attendees with a comprehensive, state-of-the-art update on the diagnosis and management of vitreoretinal diseases
    • Provide insight into new and upcoming diagnostic and therapeutic options for the medical and surgical evaluation and treatment of the various disorders affecting the posterior segment.

    Program Objectives

    Upon completion of this activity, participants should be able to:

    • Present established and innovative approaches to the medical and surgical management of vitreoretinal diseases and disorders.
    • Identify imaging tests and artificial intelligence strategies that are most helpful in the diagnosis and management of retinal conditions and discuss emerging developments in retinal imaging and diagnostics.
    • Describe new vitreoretinal surgical techniques and instrumentation.
    • Identify new developments in the understanding of hereditary retinal degenerations, retinal vascular disease, AMD and other macular diseases, pediatric retinal diseases, uveitis, and ocular oncology.
    • Summarize current and new clinical trial data for retinal diseases such as AMD, diabetic retinopathy, hereditary retinal conditions, and retinal vein occlusion.